A Bone Marrow-Targeted Nanomodulator as a Histone Lactylation Inhibitor for Reversing Immune Tolerance in Multiple Myeloma

Journal:
ACS Nano
Published:
DOI:
10.1021/acsnano.5c21396
Affiliations:
3
Authors:
9
Go to article
Institutions Authors Share
Xinqiao Hospital, Army Medical University, China
6.000000
 0.67
Chongqing University (CQU), China
2.000000
 0.22
Shandong Cancer Hospital, China
1.000000
 0.11
Interested in Pharmacology and Pharmaceutical Sciences?